These findings suggest that Sfrp5 may be able to reverse the effect of obesity, owing to its ability to sequester WNT5A [wingless-type mouse mammary tumor virus (MMTV) integration site family member 5A] from the Frz receptor and mitigate the inflammation caused by WNT5A. The gene discussed is WNT5A; the disease is obesity disorder.